Merck outguns Apple with $8bn blockbuster deal
Apple and Merck this week ended the high-grade supply freeze with the biggest deals of the year and ensured February got off to a flying start.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts